Stomach cancer risk after treatment for Hodgkin lymphoma

Journal of Clinical Oncology

Volumn 31, Issue 27, 2013, Pages 3369-3377

  Morton, Lindsay M ^a   Dores, Graça M ^a,b   Curtis, Rochelle E ^a   Lynch, Charles F ^c   Stovall, Marilyn ^d   Hall, Per ^e   Gilbert, Ethel S ^a   Hodgson, David C ^f   Storm, Hans H ^g   Johannesen, Tom Børge ⁱ   Smith, Susan A ^d   Weathers, Rita E ^d   Andersson, Michael ^h   Fossa, Sophie D ^j   Hauptmann, Michael ^k   Holowaty, Eric J ^f   Joensuu, Heikki ^l   Kaijser, Magnus ^e   Kleinerman, Ruth A ^a   Langmark, Frøydis ⁱ   Pukkala, Eero ^m   Vaalavirta, Leila ^l   Van Den Belt Dusebout, Alexandra W ^k   Fraumeni, Joseph F ^a   Travis, Lois B ⁿ   Aleman, Berthe M ^k   Van Leeuwen, Flora E ^k   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF TORONTO   (Canada)

^g DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^h Mental Health Services CPH   (Denmark)

ⁱ UNIVERSITY OF OSLO   (Norway)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k NETHERLANDS CANCER INSTITUTE   (Netherlands)

^l HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^m FINNISH CANCER REGISTRY   (Finland)

ⁿ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GYRASE INHIBITOR; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ABDOMINAL WALL MUSCULATURE; ADOLESCENT; ADULT; AGED; BODY BUILD; BREATHING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CASE CONTROL STUDY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE TONE; PRIORITY JOURNAL; RADIATION DOSE; STOMACH CANCER; STOMACH CONTENT; COHORT ANALYSIS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RISK FACTOR; STOMACH NEOPLASMS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; STOMACH NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84890369874     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.6832     Document Type: Conference Paper

References (41)

1. Howlader N, Noone A, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2009. http://seer.cancer.gov/csr/1975-2009-pops09/
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62:10-29, 2012
3. Reulen RC, Frobisher C, Winter DL, et al: Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305: 2311-2319, 2011
4. Mertens AC, Liu Q, Neglia JP, et al: Causespecific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
5. Friedman DL, Whitton J, Leisenring W, et al: Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083-1095, 2010
6. Hodgson DC, Gilbert ES, Dores GM, et al: Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25:1489-1497, 2007
7. van den Belt-Dusebout AW, Aleman BMP, Besseling G, et al: Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75:1420-1429, 2009
8. Birdwell SH, Hancock SL, Varghese A, et al: Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 37:67-73, 1997
9. Metayer C, Lynch CF, Clarke EA, et al: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443, 2000
10. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
11. van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
12. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
13. Foss Abrahamsen A, Andersen A, Nome O, et al: Long-term risk of second malignancy after treatment of Hodgkin's disease: The influence of treatment, age and follow-up time. Ann Oncol 13:1786-1791, 2002
14. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003
15. Henderson TO, Oeffinger KC, Whitton J, et al: Secondary gastrointestinal cancer in childhood cancer survivors: A cohort study. Ann Intern Med 156: 757-766, W-260, 2012
16. Nottage K, McFarlane J, Krasin MJ, et al: Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 30:2552-2558, 2012
17. Youn P, Li H, Milano MT, et al: Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: A population-based study. Ann Oncol 24:202-208, 2013
18. Gooley TA, Leisenring W, Crowley J, et al: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706, 1999
19. Stovall M, Weathers R, Kasper C, et al: Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemiological studies. Radiat Res 166:141-157, 2006
20. Leibel SA, Phillips TL: Textbook of Radiation Oncology (ed 2). Philadelphia, PA, Saunders, 2004
21. Dowd SB, Wilson BG: Encyclopedia of Radiographic Positioning, Volume 2. Philadelphia, PA, Saunders, 1995
22. Breslow NE, Day NE: Statistical methods, in Cancer Research, Volume 1: The Analysis of Case-Control Studies. Lyon, France, International Agency for Research on Cancer, 1980
23. Preston DL, Lubin JH, Pierce DA, et al: Epicure: User's Guide. Seattle, WA, HiroSoft International Corporation, 1993
24. Hong WK, Bast RC Jr, Hait WN, et al: Holland-Frei Cancer Medicine (ed 8). Shelton, CT, People's Medical Publishing House, 2010
25. Sasaki YF, Saga A, Akasaka M, et al: Organspecific genotoxicity of the potent rodent colon carcinogen 1,2-dimethylhydrazine and three hydrazine derivatives: Difference between intraperitoneal and oral administration. Mutat Res 415:1-12, 1998
26. Wilson GD, Bentzen SM, Harari PM: Biologic basis for combining drugs with radiation. Semin Radiat Oncol 16:2-9, 2006
27. Lawrence TS, Blackstock AW, McGinn C: The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13:13-21, 2003
28. Travis LB, Gospodarowicz M, Curtis RE, et al: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94: 182-192, 2002
29. Tucker MA, D'Angio GJ, Boice JD Jr, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987
30. Longo DL, Young RC, Wesley M, et al: Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 4:1295-1306, 1986
31. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990
32. Engert A, Diehl V, Franklin J, et al: Escalateddose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 27:4548-4554, 2009
33. Engert A, Plütschow A, Eich HT, et al: Reduced treatment intensity in patients with earlystage Hodgkin's lymphoma. N Engl J Med 363:640-652, 2010
34. Townsend W, Linch D: Hodgkin's lymphoma in adults. Lancet 380:836-847, 2012
35. Kaldor JM, Day NE, Hemminki K: Quantifying the carcinogenicity of antineoplastic drugs. Eur J Cancer Clin Oncol 24:703-711, 1988
36. Carr ZA, Kleinerman RA, Stovall M, et al: Malignant neoplasms after radiation therapy for peptic ulcer. Radiat Res 157:668-677, 2002
37. Boice JD Jr, Engholm G, Kleinerman RA, et al: Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116:3-55, 1988
38. Preston DL, Ron E, Tokuoka S, et al: Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64, 2007
39. United Nations Scientific Committee on the Effects of Atomic Radiation: Effects of ionizing radiation, in UNSCEAR 2006 Report, Volume 1: Report to the General Assembly, With Scientific Annexes A and B. Vienna, Austria, United Nations, 2008
40. Hodgson DC: Late effects in the era of modern therapy for Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2011:323-329, 2011
41. Ng AK, LaCasce A, Travis LB: Long-term complications of lymphoma and its treatment. J Clin Oncol 29:1885-1892, 2011